Toll-like receptor signaling: Common pathways that drive cardiovascular disease and rheumatoid arthritis
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like receptor signaling: Common pathways that drive cardiovascular disease and rheumatoid arthritis
Authors
Keywords
-
Journal
ARTHRITIS CARE & RESEARCH
Volume 63, Issue 4, Pages 500-511
Publisher
Wiley
Online
2010-10-28
DOI
10.1002/acr.20382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures
- (2014) S. M. Sacre et al. JOURNAL OF IMMUNOLOGY
- Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation
- (2014) S. Chen et al. JOURNAL OF IMMUNOLOGY
- TLR/MyD88 and Liver X Receptor Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis
- (2014) Y. Naiki et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
- (2014) N. Cheng et al. JOURNAL OF IMMUNOLOGY
- Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors
- (2010) Sandra Sacre et al. ARTHRITIS AND RHEUMATISM
- Transcriptional Regulation of the Endogenous Danger Signal Tenascin-C: A Novel Autocrine Loop in Inflammation
- (2010) Fui G. Goh et al. JOURNAL OF IMMUNOLOGY
- DAMPening Inflammation by Modulating TLR Signalling
- (2010) A. M. Piccinini et al. MEDIATORS OF INFLAMMATION
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice
- (2010) Toru Hosoi et al. PLoS One
- Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
- (2010) M. Vijay-Kumar et al. SCIENCE
- Local Interleukin-1-Driven Joint Pathology Is Dependent on Toll-Like Receptor 4 Activation
- (2009) Shahla Abdollahi-Roodsaz et al. AMERICAN JOURNAL OF PATHOLOGY
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
- (2009) T. E. Toms et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
- (2009) E Choy et al. ANNALS OF THE RHEUMATIC DISEASES
- Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling
- (2009) Clett Erridge et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High expression level of Toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease
- (2009) So Kuwahata et al. ATHEROSCLEROSIS
- Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
- (2009) Claudia Monaco et al. CIRCULATION
- Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
- (2009) Fatih Arslan et al. CIRCULATION
- Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
- (2009) Soo-Ho Choi et al. CIRCULATION RESEARCH
- Targeting Toll-like Receptors in Autoimmunity
- (2009) K. Midwood et al. CURRENT DRUG TARGETS
- The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
- (2009) Luke A. J. O'Neill IMMUNOLOGICAL REVIEWS
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inflaming metastasis
- (2009) Alberto Mantovani NATURE
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
- (2009) Kim Midwood et al. NATURE MEDICINE
- Are new agents needed to treat RA?
- (2009) Peter E. Lipsky Nature Reviews Rheumatology
- The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus
- (2009) Louise E Full et al. ARTHRITIS RESEARCH & THERAPY
- The role of tenascin-C in tissue injury and tumorigenesis
- (2009) Kim S. Midwood et al. Journal of Cell Communication and Signaling
- Athsq1 Is an Atherosclerosis Modifier Locus With Dramatic Effects on Lesion Area and Prominent Accumulation of Versican
- (2008) Sara Bretschger Seidelmann et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The orchestra of toll-like receptors and their potential role in frequently occurring rheumatic conditions
- (2008) Mieke F. Roelofs et al. ARTHRITIS AND RHEUMATISM
- High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study
- (2008) Hilal Maradit Kremers et al. ARTHRITIS AND RHEUMATISM
- Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis
- (2008) John W. Rice et al. ARTHRITIS AND RHEUMATISM
- A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation
- (2008) Jin-Gu Lee et al. CELLULAR SIGNALLING
- Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries
- (2008) Olga Pryshchep et al. CIRCULATION
- Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages
- (2008) Laurent Yvan-Charvet et al. CIRCULATION
- Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis
- (2008) Karin Tran-Lundmark et al. CIRCULATION RESEARCH
- Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
- (2008) Akio Kawakami et al. CIRCULATION RESEARCH
- Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein
- (2008) Yun Soo Bae et al. CIRCULATION RESEARCH
- Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma
- (2008) C. Erridge et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Structures of the Toll-like Receptor Family and Its Ligand Complexes
- (2008) Mi Sun Jin et al. IMMUNITY
- Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
- (2008) Shahla Abdollahi-Roodsaz et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
- (2008) Evis Harja et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
- (2008) Adam E. Mullick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice
- (2008) Roberto Roncon-Albuquerque et al. LIFE SCIENCES
- Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings
- (2008) Monika Madan et al. PLoS One
- TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells
- (2008) Taek-Jong Hong et al. VASCULAR PHARMACOLOGY
- High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
- (2008) David S Pisetsky et al. ARTHRITIS RESEARCH & THERAPY
- Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness
- (2007) A.H. Schoneveld et al. ATHEROSCLEROSIS
- Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids
- (2007) Xinyan Liu et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now